The study is chaired by Andrew T. Parsa, MD, PhD, who is Northwestern Memorial Hospital’s chair of neurosurgery. The trails are funded by the National Cancer Institute.
While Northwestern Memorial has just enrolled as the first Midwest and third national participant, the trial will eventually enroll more than 200 patients with recurrent glioblastoma multiforme, a common and aggressive malignant brain tumor.
Researchers will perform treatments to see if vaccines based on individuals’ tumor characteristics are effective in slowing or stopping glioblastoma multiforme altogether.
More Articles on Key Specialties:
Texas Medical Center’s Anderson Cancer Center Receives $5M Neuroscience Donation
French Hospital New Cardiac Suite Under Construction
University of Rochester Medical Center, Interlakes Oncology Announce Intent to Collaborate
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
